Lo Vang

712 total citations
12 papers, 374 citations indexed

About

Lo Vang is a scholar working on Infectious Diseases, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Lo Vang has authored 12 papers receiving a total of 374 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 7 papers in Epidemiology and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Lo Vang's work include Mosquito-borne diseases and control (6 papers), Viral Infections and Vectors (4 papers) and HIV Research and Treatment (3 papers). Lo Vang is often cited by papers focused on Mosquito-borne diseases and control (6 papers), Viral Infections and Vectors (4 papers) and HIV Research and Treatment (3 papers). Lo Vang collaborates with scholars based in United States, United Kingdom and China. Lo Vang's co-authors include Jeff Alexander, Michael Diamond, Daved H. Fremont, Jonathan D. Smith, Arthur S. Kim, Darly J. Manayani, Brittany Smith, Carla Uranga, Ming Cheng and Katherine Basore and has published in prestigious journals such as Cell, PLoS ONE and Journal of Virology.

In The Last Decade

Lo Vang

12 papers receiving 366 citations

Peers

Lo Vang

PHEOH

EPIDE

IMMUN

Valérie Najburg France

Jesica M. Levingston Macleod Argentina

Elyse R. Nagle United States

Nicole N. Haese United States

Althea A. Capul United States

Brian E. Dawes United States

Darly J. Manayani United States

Sandra Sparacio Germany

Jason Mendy United States

Sumathy Velumani Singapore

Valérie Najburg France

Lo Vang

294 ×1.3

201 ×1.0

PHEOH

177 ×1.3

EPIDE

146 ×1.9

IMMUN

144 ×1.9

Citations per year, relative to Lo Vang Lo Vang (= 1×) peers Valérie Najburg

Countries citing papers authored by Lo Vang

Since Specialization

Citations

This map shows the geographic impact of Lo Vang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lo Vang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lo Vang more than expected).

Fields of papers citing papers by Lo Vang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lo Vang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lo Vang. The network helps show where Lo Vang may publish in the future.

Co-authorship network of co-authors of Lo Vang

This figure shows the co-authorship network connecting the top 25 collaborators of Lo Vang. A scholar is included among the top collaborators of Lo Vang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lo Vang. Lo Vang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Raju, Saravanan, Lucas J. Adams, James T. Earnest, et al.. (2023). A chikungunya virus–like particle vaccine induces broadly neutralizing and protective antibodies against alphaviruses in humans. Science Translational Medicine. 15(696). eade8273–eade8273. 25 indexed citations

Thompson, Danielle, Darly J. Manayani, Jason Mendy, et al.. (2022). Zika virus-like particle vaccine fusion loop mutation increases production yield but fails to protect AG129 mice against Zika virus challenge. PLoS neglected tropical diseases. 16(7). e0010588–e0010588. 4 indexed citations

Vang, Lo, Christopher S. Morello, Jason Mendy, et al.. (2021). Zika virus-like particle vaccine protects AG129 mice and rhesus macaques against Zika virus. PLoS neglected tropical diseases. 15(3). e0009195–e0009195. 19 indexed citations

McAllister, Nicole, Yan Liu, Lisete M. Silva, et al.. (2020). Chikungunya Virus Strains from Each Genetic Clade Bind Sulfated Glycosaminoglycans as Attachment Factors. Journal of Virology. 94(24). 24 indexed citations

Basore, Katherine, Arthur S. Kim, Christopher A. Nelson, et al.. (2019). Cryo-EM Structure of Chikungunya Virus in Complex with the Mxra8 Receptor. Cell. 177(7). 1725–1737.e16. 112 indexed citations

Espinosa, Diego A., Jason Mendy, Darly J. Manayani, et al.. (2017). Passive Transfer of Immune Sera Induced by a Zika Virus-Like Particle Vaccine Protects AG129 Mice Against Lethal Zika Virus Challenge. EBioMedicine. 27. 61–70. 42 indexed citations

Alexander, Jeff, Jason Mendy, Lo Vang, et al.. (2013). Pre-Clinical Development of a Recombinant, Replication-Competent Adenovirus Serotype 4 Vector Vaccine Expressing HIV-1 Envelope 1086 Clade C. PLoS ONE. 8(12). e82380–e82380. 18 indexed citations

Alexander, Jeff, Simone Visosky Ward, Jason Mendy, et al.. (2012). Pre-Clinical Evaluation of a Replication-Competent Recombinant Adenovirus Serotype 4 Vaccine Expressing Influenza H5 Hemagglutinin. PLoS ONE. 7(2). e31177–e31177. 44 indexed citations

Alexander, Jeff, Marc Gurwith, Jason Mendy, et al.. (2012). Development of a HIV-1 vaccine using an orally-administered, replication-competent adenovirus serotype 4 vector expressing Env clade C glycoprotein. Retrovirology. 9(S2). 1 indexed citations

10.

Kotturi, Maya F., Jason Botten, John Sidney, et al.. (2009). A Multivalent and Cross-Protective Vaccine Strategy against Arenaviruses Associated with Human Disease. PLoS Pathogens. 5(12). e1000695–e1000695. 35 indexed citations

11.

Walker, L E, Lo Vang, Xuefei Shen, et al.. (2009). Design and preclinical development of a recombinant protein and DNA plasmid mixed format vaccine to deliver HIV-derived T-lymphocyte epitopes. Vaccine. 27(50). 7087–7095. 7 indexed citations

12.

Alexander, Jeff, Pamuk Bilsel, Marie‐France del Guercio, et al.. (2009). Universal influenza DNA vaccine encoding conserved CD4+ T cell epitopes protects against lethal viral challenge in HLA-DR transgenic mice. Vaccine. 28(3). 664–672. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact